Chargement en cours...
Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
Gastric cancer (GC) is the fourth most common cancer and the second most frequent cause of cancer-related deaths, accounting for 10.4% of cancer deaths worldwide. Despite the improvements, estimated cure rates for patients with advanced stages remain poor, and in the metastatic setting, chemotherapy...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3255571/ https://ncbi.nlm.nih.gov/pubmed/22253528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/437348 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|